Literature DB >> 26592842

Analysis of persistence of human papillomavirus infection in men evaluated by sampling multiple genital sites.

G Capra1, A G Nyitray, B Lu, A Perino, R Marci, R Schillaci, D Matranga, A Firenze, M Caleca, C Bellavia, F Guarneri, A Giuliano, L Giovannelli.   

Abstract

OBJECTIVE: Although human papillomavirus (HPV) infection has been studied extensively in women, data on male infection are limited. The purpose of this study was to investigate persistence of HPV infection at multiple genital sites in men and to define potential associations with socio-behavioural characteristics. PATIENTS AND METHODS: Penile, urethral and seminal specimens were tested by the INNO-LiPA HPV system (Innogenetics) and a PCR assay. Persistence was defined as the detection of same HPV type at ≥ 2 consecutive visits. The Kaplan-Meier method and the log-rank test were applied to estimate the likelihood of persistence.
RESULTS: A total of 50 men (median age: 33 years) were followed for a median of 14.7 months. Altogether, 49%, 36%, 26% and 11% of baseline HPV-positive men had 6-, 12-, 18- and 24-month persistent infection with any HPV type, respectively. The 6-, 12- and 18- month persistence was more common for oncogenic HPV infections; 24-month persistence was similar. The median duration of persistence was 21.7 months for any HPV. The median duration of persistence for any HPV type was significantly longer in the penile sample (22.5 months, 95% CI: 18.3-26.7) than the semen sample (15.3 months, 95% CI: 14.5-16.1).
CONCLUSIONS: Over a third of type-specific HPV infections in men remained persistent over a 24-month period. The median duration of HPV infection was longer in penile samples compared to seminal samples. As being increasing the attention of HPV vaccination as a potential preventive approach also for men, it is imperative to obtain additional insight on natural history of HPV infection in men, particularly as far as incidence and duration are concerned.

Entities:  

Mesh:

Year:  2015        PMID: 26592842

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  13 in total

1.  The impact of environmental and behavioural cofactors on the development of cervical disorders in HR-HPV-infected women in Serbia.

Authors:  D Tasic; I Lazarevic; A Knezevic; L Tasic; A Pikula; Z Perisic; T Jovanovic; M Cupic
Journal:  Epidemiol Infect       Date:  2018-06-20       Impact factor: 4.434

2.  Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015.

Authors:  Y J Park; J M Kim; B R Lee; T H Kim; E G Lee
Journal:  Epidemiol Infect       Date:  2017-12-13       Impact factor: 4.434

3.  Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily.

Authors:  Giuseppina Capra; Lucia Giovannelli; Domenica Matranga; Carmelina Bellavia; Maria Francesca Guarneri; Teresa Fasciana; Giovanna Scaduto; Alberto Firenze; Alessandra Vassiliadis; Antonio Perino
Journal:  Hum Vaccin Immunother       Date:  2017-06-08       Impact factor: 3.452

4.  Male Partners of Infertile Couples with Seminal Infections of Human Papillomavirus Have Impaired Fertility Parameters.

Authors:  Edilson Damke; Fábio A Kurscheidt; Valério A Balani; Karen I Takeda; Mary M T Irie; Fabrícia Gimenes; Marcia E L Consolaro
Journal:  Biomed Res Int       Date:  2017-08-01       Impact factor: 3.411

5.  The risk of human papillomavirus infection for male fertility abnormality: a meta-analysis.

Authors:  Yi-Quan Xiong; Yan-Xia Chen; Ming-Ji Cheng; Wen-Qiao He; Qing Chen
Journal:  Asian J Androl       Date:  2018 Sep-Oct       Impact factor: 3.285

6.  Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa.

Authors:  Admire Chikandiwa; Pedro T Pisa; Etienne E Muller; Catherine Tamalet; Philippe Mayaud; Matthew F Chersich; Sinead Delany-Moretlwe
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

7.  HPV infection in semen: results from a new molecular approach.

Authors:  G Capra; R Schillaci; L Bosco; M C Roccheri; A Perino; M A Ragusa
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

8.  Prevalence and genotypes of anal human papillomavirus infection among HIV-positive vs. HIV-negative men in Taizhou, China.

Authors:  X Liu; H Lin; X Chen; W Shen; X Ye; Y Lin; Z Lin; S Zhou; M Gao; Y Ding; N He
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

9.  Viral infections and implications for male reproductive health.

Authors:  Thiago A Teixeira; Yasmin C Oliveira; Felipe S Bernardes; Esper G Kallas; Amaro N Duarte-Neto; Sandro C Esteves; Joël R Drevet; Jorge Hallak
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

Review 10.  Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.

Authors:  Thomas Harder; Ole Wichmann; Stefanie J Klug; Marianne A B van der Sande; Miriam Wiese-Posselt
Journal:  BMC Med       Date:  2018-07-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.